(Q41120633)

27 September 2017

In vitro forecasting of drugs that may interfere with codeine bioactivation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1425809

25 September 2022

author name string

P. Dayer

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1425809

25 September 2022

J. Desmeules

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1425809

25 September 2022

R. Striberni

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1425809

25 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1425809

25 September 2022

publication date

1 April 1992

1 reference

European Journal of Drug Metabolism and Pharmacokinetics

27 September 2017

1 reference

27 September 2017

17

1 reference

27 September 2017

115-120

1 reference

27 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03188779

27 September 2017

0 references

cites work

Codeine O-demethylation co-segregates with polymorphic debrisoquine hydroxylation

1 reference

https://api.crossref.org/works/10.1007%2FBF03188779

Polymorphic formation of morphine from codeine in poor and extensive metabolizers of dextromethorphan: relationship to the presence of immunoidentified cytochrome P-450IID1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03188779

The determination of enzyme inhibitor constants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03188779

A dose-effect study of the in vivo inhibitory effect of quinidine on sparteine oxidation in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03188779

Dextromethorphan O-demethylation in liver microsomes as a prototype reaction to monitor cytochrome P-450 db1 activity

21 January 2018

1 reference

12 December 2020

Polymorphic O-demethylation of codeine

1 reference

12 December 2020

The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation

1 reference

12 December 2020

Importance of oxidative polymorphism and levomepromazine treatment on the steady-state blood concentrations of clomipramine and its major metabolites

1 reference

12 December 2020

Characterization of the common genetic defect in humans deficient in debrisoquine metabolism

1 reference

12 December 2020

Human P450PCN1: sequence, chromosome localization, and direct evidence through cDNA expression that P450PCN1 is nifedipine oxidase

1 reference

12 December 2020

Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI)

1 reference

12 December 2020

The genetic polymorphism of debrisoquine/sparteine metabolism--clinical aspects

1 reference

12 December 2020

Expression of a human liver cytochrome P-450 protein with tolbutamide hydroxylase activity in Saccharomyces cerevisiae

1 reference

12 December 2020

Single-dose quinidine treatment inhibits metoprolol oxidation in extensive metabolizers

1 reference

12 December 2020

Impact of environmental and genetic factors on codeine analgesia

1 reference

12 December 2020

Inhibition of desmethylimipramine 2-hydroxylation by drugs in human liver microsomes.

1 reference

12 December 2020

Enzymatic basis of the debrisoquine/sparteine-type genetic polymorphism of drug oxidation. Characterization of bufuralol 1'-hydroxylation in liver microsomes of in vivo phenotyped carriers of the genetic deficiency

1 reference

12 December 2020

Recent developments in hepatic drug oxidation. Implications for clinical pharmacokinetics

1 reference

12 December 2020

Expression of a human P-450IIC gene in yeast cells using galactose-inducible expression system

1 reference

12 December 2020

Glucuronidation of morphine in human liver and interaction with oxazepam

1 reference

12 December 2020

Clinical significance of the sparteine/debrisoquine oxidation polymorphism

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03188779

1 reference

Dimensions Publication ID

27 September 2017

0 references

1 reference